Views

CrossRef citations to date

Altmetric

Letters to the Editor

Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting

Marzia Varettonia Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Silvia Mangiacavallia Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Sara Rattottia Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Claudio Salvatore Cartiaa Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Chiara Cavallonia Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Franca Rossettia Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Virginia Valeria Ferrettib Department of Molecular Medicine, University of Pavia, Pavia, Italy

Fabio Bergaminic Service of Biometry and Clinical Epidemiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Chiara Trottic Service of Biometry and Clinical Epidemiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Nicolas Fiorellic Service of Biometry and Clinical Epidemiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Giuseppina Paganic Service of Biometry and Clinical Epidemiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Caterina Zerbic Service of Biometry and Clinical Epidemiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Jacqueline Ferraric Service of Biometry and Clinical Epidemiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Caterina Cristinellic Service of Biometry and Clinical Epidemiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Alba Muzzid Medical Direction, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Carlo Marenad Medical Direction, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Fausto Baldantie Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy;f Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, Pavia, Italy

Raffaele Brunof Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, Pavia, Italy;g Division of Infectious Diseases, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Luca Arcainia Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy;b Department of Molecular Medicine, University of Pavia, Pavia, ItalyCorrespondence[email protected]

show all

References

Kuderer NM, Choueiri TK, Shah DP, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020;395(10241):1907–1918.
PubMed Web of Science ®Google Scholar
Lee LYW, Cazier JB, Starkey T, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020;395(10241):1919–1926.
PubMed Web of Science ®Google Scholar
Yang K, Sheng Y, Huang C, et al. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study. Lancet Oncol. 2020;21(7):904–913.
PubMed Web of Science ®Google Scholar
Jee J, Foote MB, Lumish M, et al. Chemotherapy and COVID-19 outcomes in patients with cancer. J Clin Oncol. 2020;38(30):3538–3546.
PubMed Web of Science ®Google Scholar
Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335–337.
PubMed Web of Science ®Google Scholar
Passamonti F, Cattaneo C, Arcaini L, et al. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. Lancet Haematol. 2020;7(10):e737–e745.
PubMed Web of Science ®Google Scholar
Sayampanath AA, Heng CS, Pin PH, et al. Infectivity of asymptomatic versus symptomatic COVID-19. Lancet. 2021;397(10269):93–94.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date